96 related articles for article (PubMed ID: 28757886)
1. The influence of a gene-expression signature on the treatment of diagnostically challenging melanocytic lesions.
Cockerell C; Tschen J; Billings SD; Evans B; Brown K; Rock C; Clarke LE
Per Med; 2017 Mar; 14(2):123-130. PubMed ID: 28757886
[TBL] [Abstract][Full Text] [Related]
2. The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists.
Cockerell CJ; Tschen J; Evans B; Bess E; Kidd J; Kolquist KA; Rock C; Clarke LE
Medicine (Baltimore); 2016 Oct; 95(40):e4887. PubMed ID: 27749545
[TBL] [Abstract][Full Text] [Related]
3. Clinical validity of a gene expression signature in diagnostically uncertain neoplasms.
Clarke LE; Mabey B; Flake Ii DD; Meek S; Cassarino DS; Duncan LM; High WA; Napekoski KM; Prieto VG; Tetzlaff MT; Vitale P; Elder DE
Per Med; 2020 Sep; 17(5):361-371. PubMed ID: 32915688
[No Abstract] [Full Text] [Related]
4. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category.
Augsburger JJ; Corrêa ZM; Schneider S; Yassin RS; Robinson-Smith T; Ehya H; Trichopoulos N
Trans Am Ophthalmol Soc; 2002; 100():225-32; discussion 232-4. PubMed ID: 12545696
[TBL] [Abstract][Full Text] [Related]
5. Weight of decision-making impairs clinical assessment of melanocytic lesions.
Gächter T; Mühleisen B; Schärer L; Dummer R; Burg G; Hofbauer GF
J Cutan Med Surg; 2007; 11(1):9-18. PubMed ID: 17274934
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of COX-2 protein expression in melanocytic nevi in children].
Kubus M; Andrzejewska E; Nejc D; Kobos J; Taran K
Pol Merkur Lekarski; 2013 Aug; 35(206):82-4. PubMed ID: 24052986
[TBL] [Abstract][Full Text] [Related]
7. Melanocytic Nevi of Special Sites.
Ahn CS; Guerra A; Sangüeza OP
Am J Dermatopathol; 2016 Dec; 38(12):867-881. PubMed ID: 27870726
[TBL] [Abstract][Full Text] [Related]
8. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
[TBL] [Abstract][Full Text] [Related]
9. Sampling of melanocytic nevi for research purposes: a prospective, pilot study to determine effect on diagnosis.
Florell SR; Smoller BR; Boucher KM; Grossman D; Harris RM; Bowen GM; Leachman SA
J Am Acad Dermatol; 2008 Nov; 59(5):814-21. PubMed ID: 19119097
[TBL] [Abstract][Full Text] [Related]
10. A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management.
Witkowski A; Jarell AD; Ahmed KL; Siegel JJ; Russell BH; Rogers JH; Goldberg MS; Fernandes NF; Ludzik J; Farberg AS
Melanoma Manag; 2024; 11(1):MMT68. PubMed ID: 38812731
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
12. Relative frequency of solitary melanocytic lesions of the oral mucosa.
Buchner A; Merrell PW; Carpenter WM
J Oral Pathol Med; 2004 Oct; 33(9):550-7. PubMed ID: 15357676
[TBL] [Abstract][Full Text] [Related]
13. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
15. Analytical validation of a melanoma diagnostic gene signature using formalin-fixed paraffin-embedded melanocytic lesions.
Warf MB; Flake DD; Adams D; Gutin A; Kolquist KA; Wenstrup RJ; Roa BB
Biomark Med; 2015; 9(5):407-16. PubMed ID: 25815401
[TBL] [Abstract][Full Text] [Related]
16. A nongrading histologic approach to Clark (dysplastic) nevi: A potential to decrease the excision rate.
Lozeau DF; Farber MJ; Lee JB
J Am Acad Dermatol; 2016 Jan; 74(1):68-74. PubMed ID: 26549250
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Kittler H; Pehamberger H; Wolff K; Binder M
J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
Gerami P; Alsobrook JP; Palmer TJ; Robin HS
J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
[TBL] [Abstract][Full Text] [Related]
19. Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic.
Hawryluk EB; Sober AJ; Piris A; Nazarian RM; Hoang MP; Tsao H; Mihm MC; Duncan LM
J Am Acad Dermatol; 2012 Oct; 67(4):727-35. PubMed ID: 22521204
[TBL] [Abstract][Full Text] [Related]
20. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
